Molecular markers and targets in melanoma

C Teixido, P Castillo, C Martinez-Vila, A Arance, L Alos - Cells, 2021 - mdpi.com
Melanoma develops as a result of several genetic alterations, with UV radiation often acting
as a mutagenic risk factor. Deep knowledge of the molecular signaling pathways of different …

BRAF as therapeutic target in melanoma

C Wellbrock, A Hurlstone - Biochemical pharmacology, 2010 - Elsevier
BRAF is a member of the RAF kinase family, which acts in the ERK/MAP kinase pathway, a
signalling cascade that regulates cellular proliferation, differentiation and survival. Single …

A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms

P Gerami, G Li, P Pouryazdanparast… - The American journal …, 2012 - journals.lww.com
The diagnosis of certain melanocytic proliferations remains one of the most challenging
areas in pathology. In recent times, fluorescence in situ hybridization (FISH) has emerged as …

Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe

B Gammon, B Beilfuss, J Guitart… - The American journal of …, 2012 - journals.lww.com
The use of molecular diagnostic methods such as fluorescence in situ hybridization (FISH)
for challenging melanocytic neoplasms is becoming more widespread. In light of the …

Dysplastic nevus: Fact and fiction

CO Rosendahl, JM Grant-Kels, SKT Que - Journal of the American …, 2015 - Elsevier
The term “dysplastic nevus”(DN) implies that this nevus exists as a distinct and defined entity
of potential detriment to its host. We examine the current data, which suggest that this entity …

[HTML][HTML] Genetic alterations in main candidate genes during melanoma progression

MC Sini, V Doneddu, P Paliogiannis, M Casula… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Cutaneous melanoma is a common and aggressive human skin cancers. Much is actually
known about the molecular mechanisms underlying melanoma pathogenesis. The aim of …

Immunohistochemical expression of p16 in melanocytic lesions: an updated review and meta-analysis

SS Koh, DS Cassarino - Archives of Pathology & …, 2018 - meridian.allenpress.com
Context.—Making an accurate diagnosis for melanocytic lesions has always been
challenging for pathologists, especially when dealing with difficult-to-diagnose cases …

Conditional ablation of Ikkb inhibits melanoma tumor development in mice

J Yang, R Splittgerber, FE Yull… - The Journal of …, 2010 - Am Soc Clin Investig
Several lines of evidence suggest that tumor cells show elevated activity of the NF-κB
transcription factor, a phenomenon often resulting from constitutive activity of IκB kinase β …

The “dysplastic” nevus

RJ Friedman, MJ Farber, MA Warycha… - Clinics in …, 2009 - Elsevier
Dysplastic nevi have become an increasing focus clinically, with evidence that they are
associated with a higher risk of develo** melanoma. However, there still is contention …

The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management

K Duffy, D Grossman - Journal of the American Academy of Dermatology, 2012 - Elsevier
The dysplastic nevus is a discreet histologic entity that exhibits some clinical and histologic
features overlap** with common nevi and melanoma. These overlap** features present …